These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 11474135

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Gorgoulis VG, Zacharatos P, Kotsinas A, Mariatos G, Liloglou T, Vogiatzi T, Foukas P, Rassidakis G, Garinis G, Ioannides T, Zoumpourlis V, Bramis J, Michail PO, Asimacopoulos PJ, Field JK, Kittas C.
    Mol Med; 2000 Mar; 6(3):208-37. PubMed ID: 10965496
    [Abstract] [Full Text] [Related]

  • 3. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
    Gorgoulis VG, Kotsinas A, Zacharatos P, Mariatos G, Liloglou T, Tsoli E, Kokotas S, Fassoulas C, Field JK, Kittas C.
    Cancer; 2000 Nov 01; 89(9):1933-45. PubMed ID: 11064350
    [Abstract] [Full Text] [Related]

  • 4. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
    Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C.
    Am J Pathol; 1998 Dec 01; 153(6):1749-65. PubMed ID: 9846966
    [Abstract] [Full Text] [Related]

  • 5. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
    Kinoshita I, Dosaka-Akita H, Mishina T, Akie K, Nishi M, Hiroumi H, Hommura F, Kawakami Y.
    Cancer Res; 1996 Dec 15; 56(24):5557-62. PubMed ID: 8971152
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H, Ohta M, Tanaka H, Sakaguchi M, Fujii Y, Miyoshi S, Matsuda H.
    J Surg Oncol; 2002 Dec 15; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [Abstract] [Full Text] [Related]

  • 7. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C.
    J Pathol; 2001 Jan 15; 193(1):55-65. PubMed ID: 11169516
    [Abstract] [Full Text] [Related]

  • 8. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG, Zacharatos P, Mariatos G, Liloglou T, Kokotas S, Kastrinakis N, Kotsinas A, Athanasiou A, Foukas P, Zoumpourlis V, Kletsas D, Ikonomopoulos J, Asimacopoulos PJ, Kittas C, Field JK.
    Cancer Res; 2001 Jan 15; 61(2):538-49. PubMed ID: 11212247
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 15; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas.
    Saito T, Nakajima T, Mogi K.
    J Oral Pathol Med; 1999 May 15; 28(5):226-32. PubMed ID: 10226946
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
    Dworakowska D, Jassem E, Jassem J, Karmoliński A, Lapiński M, Tomaszewski D, Rzyman W, Jaśkiewicz K, Sworczak K, Grossman AB.
    Lung Cancer; 2009 Oct 15; 66(1):127-33. PubMed ID: 19200616
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1.
    Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, Kougiou D, Kouloukoussa M, Nishitani H, Papavassiliou AG, Lygerou Z, Gorgoulis VG.
    Am J Pathol; 2004 Oct 15; 165(4):1351-65. PubMed ID: 15466399
    [Abstract] [Full Text] [Related]

  • 13. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 15; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 14. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
    Hedberg Y, Ljungberg B, Roos G, Landberg G.
    Int J Cancer; 2004 Mar 20; 109(2):189-93. PubMed ID: 14750168
    [Abstract] [Full Text] [Related]

  • 15. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas.
    Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, Kletsas D, Asimacopoulos PJ, Agnantis N, Kittas C, Papavassiliou AG.
    J Pathol; 2002 Oct 20; 198(2):142-56. PubMed ID: 12237873
    [Abstract] [Full Text] [Related]

  • 16. Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance.
    Haitel A, Wiener HG, Neudert B, Marberger M, Susani M.
    Urology; 2001 Sep 20; 58(3):477-81. PubMed ID: 11549509
    [Abstract] [Full Text] [Related]

  • 17. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD.
    Clin Cancer Res; 1999 Apr 20; 5(4):791-800. PubMed ID: 10213214
    [Abstract] [Full Text] [Related]

  • 18. Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status.
    Mariatos G, Gorgoulis VG, Zacharatos P, Kotsinas A, Vogiatzi T, Rassidakis G, Foukas P, Liloglou T, Tiniakos D, Angelou N, Manolis EN, Veslemes M, Field JK, Kittas C.
    Int J Cancer; 2000 Mar 20; 89(2):133-41. PubMed ID: 10754490
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression.
    Dworakowska D, Jassem E, Jassem J, Karmoliński A, Dworakowski R, Wirth T, Gruchała M, Rynkiewicz A, Skokowski J, Yla-Herttuala S, Jaśkiewicz K, Czestochowska E.
    J Cancer Res Clin Oncol; 2005 Sep 20; 131(9):617-23. PubMed ID: 16028106
    [Abstract] [Full Text] [Related]

  • 20. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M.
    Hepatology; 1999 Jul 20; 30(1):90-9. PubMed ID: 10385644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.